Survival Benefit Relative to Treatment Modalities Among Patients with Very Early Intrahepatic Cholangiocarcinoma: an Analysis of the National Cancer Database
-
Published:2023-10
Issue:10
Volume:27
Page:2103-2113
-
ISSN:1091-255X
-
Container-title:Journal of Gastrointestinal Surgery
-
language:en
-
Short-container-title:Journal of Gastrointestinal Surgery
Author:
Endo Yutaka,
Sasaki Kazunari,
Munir Muhammad Musaab,
Woldesenbet Selamawit,
Resende Vivian,
Rawicz-Pruszyński Karol,
Waqar Usama,
Mavani Parit,
Katayama Erryk,
Yang Jason,
Khalil Mujtaba,
Khan Muhammad Muntazir Mehdi,
Kitago Minoru,
Pawlik Timothy M.ORCID
Subject
Gastroenterology,Surgery
Reference42 articles.
1. Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center;Singal;J Cancer Res Clin Oncol.,2011
2. Changing international trends in mortality rates for liver, biliary and pancreatic tumours;Khan;J Hepatol.,2002
3. Lima HA, Moazzam Z, Endo Y, Alaimo L, Diaz A, Woldesenbet S et al. Impact of the Affordable Care Act on Presentation, Treatment, and Outcomes of Intrahepatic Cholangiocarcinoma. J Gastrointest Surg. 2022. https://doi.org/10.1007/s11605-022-05496-6.
4. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma;Palmer;J Hepatol.,2012
5. Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma;Kubo;Liver Cancer.,2022